Latest news with #AmitriptylineHydrochlorideTablets
Economic Times
25-06-2025
- Business
- Economic Times
Stocks in news: Vodafone Idea, Vedanta, Hindalco Industries, Mastek, Aurobindo Pharma
Live Events (You can now subscribe to our (You can now subscribe to our ETMarkets WhatsApp channel It turned out to be an eventful day for market participants on Tuesday, as the benchmark index witnessed sharp swings in both directions before finally closing with marginal gains. In today's trade, shares of Vodafone Idea Aurobindo Pharma among others will be in focus due to various news Gautam Adani's Group, mining mogul Anil Agarwal's Vedanta , and Dalmia Bharat Cement have submitted their resolution plans to acquire Jaiprakash Associates through an insolvency process, PTI an unusual move, the government has demoted Union Bank of India Executive Director (ED) Pankaj Dwivedi to General Manager (GM).Hospital network Narayana Health has acquired prime land parcels worth Rs 246 crore on Bannerghatta Main Road, a rapidly emerging healthcare corridor in Bengaluru, marking one of the most significant institutional healthcare real estate transactions of Jha resigned as the Chief Financial Officer of the company with effect from July Chemicals and Pharma has received final approval from the US FDA for its abbreviated new drug application (ANDA) for Amitriptyline Hydrochloride Tablets Krishnasamy resigned as the chief technology officer - Actuation, Control & Fluid Management Systems of the company with effect from June Projects secured a large order (ranging Rs 100-200 crore) for establishment of 400kV GIS & 765kV AIS extension Pharma arm CuraTeQ Biologics received approval for biosimilar Dyrupeg from UK's Medicines And Healthcare Products Regulatory Agency (MHRA).Hindalco Industries announced the acquisition of a 100% equity stake in US-based AluChem Companies, Inc for an enterprise value of $125 Idea clarified that it has not received any communication from the government regarding reported relief on its adjusted gross revenue (AGR) dues of around Rs 84,000 crore.
Time of India
25-06-2025
- Business
- Time of India
Stocks in news: Vodafone Idea, Vedanta, Hindalco Industries, Mastek, Aurobindo Pharma
Live Events (You can now subscribe to our (You can now subscribe to our ETMarkets WhatsApp channel It turned out to be an eventful day for market participants on Tuesday, as the benchmark index witnessed sharp swings in both directions before finally closing with marginal gains. In today's trade, shares of Vodafone Idea Aurobindo Pharma among others will be in focus due to various news Gautam Adani's Group, mining mogul Anil Agarwal's Vedanta , and Dalmia Bharat Cement have submitted their resolution plans to acquire Jaiprakash Associates through an insolvency process, PTI an unusual move, the government has demoted Union Bank of India Executive Director (ED) Pankaj Dwivedi to General Manager (GM).Hospital network Narayana Health has acquired prime land parcels worth Rs 246 crore on Bannerghatta Main Road, a rapidly emerging healthcare corridor in Bengaluru, marking one of the most significant institutional healthcare real estate transactions of Jha resigned as the Chief Financial Officer of the company with effect from July Chemicals and Pharma has received final approval from the US FDA for its abbreviated new drug application (ANDA) for Amitriptyline Hydrochloride Tablets Krishnasamy resigned as the chief technology officer - Actuation, Control & Fluid Management Systems of the company with effect from June Projects secured a large order (ranging Rs 100-200 crore) for establishment of 400kV GIS & 765kV AIS extension Pharma arm CuraTeQ Biologics received approval for biosimilar Dyrupeg from UK's Medicines And Healthcare Products Regulatory Agency (MHRA).Hindalco Industries announced the acquisition of a 100% equity stake in US-based AluChem Companies, Inc for an enterprise value of $125 Idea clarified that it has not received any communication from the government regarding reported relief on its adjusted gross revenue (AGR) dues of around Rs 84,000 crore.
